As of 2025-08-07, the Relative Valuation of Sigilon Therapeutics, Inc. (SGTX) is (305.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of Sigilon Therapeutics, Inc. based on Relative Valuation is -1461.8%.
The range of the Relative Valuation is (204.98) - (380.46) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 25.8x | 19.6x |
| Forward P/E multiples | 13.9x - 30.0x | 22.0x |
| Fair Price | (204.98) - (380.46) | (305.99) |
| Upside | -1012.2% - -1793.2% | -1461.8% |
| Date | P/E |